HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

531.686

-1.161-0.22%

Number of Gainers:10

Number of Losers:23

Number of Flat:- -

PE:- -

High:543.539

Open:532.796

Low:528.924

Close:532.848

Volume:72.91M

Turnover:1.77B

Market Cap:339.49B

Float Cap:302.56B

Loading ...

Why InnoCare Pharma (SEHK:9969) Is Up 12.9% After Dual Breakthrough Therapy Wins in Cancer and Autoimmune Disease - And What's Next

Simply Wall St.

AI-Driven Drug Discovery Nears Reality: From Molecule Generation to Clinical Validation

Drug Innovation and CRO Sectors Surge as Mid-Year Reports Validate Sector Uptrend

AI Drug Discovery Sparks 'Tool Seller' Surge, CXO Giants Break Multiple Records! Innovative Drugs Next in Line? Fund Manager's Latest Analysis!

Sichuan Huiyu Pharmaceutical Secures European Marketing Approvals for Two Injectable Drugs

Peijia Medical Schedules Board Meeting to Review Interim Results, Dividend Recommendation

MGI Tech's AI Unit Targets National Labs and Pharma Firms with Autonomous Lab Tools

SDIC Securities: Pharmaceutical Equipment Sector Enters New Quality Upgrade Phase, Focus on Top Domestic Firms

Zai Lab Ltd : Jefferies Cuts Target Price to $36 from $52

THOMSON REUTERS

Akeso Doses First Patient in Phase II Trial of Ak146d1 ADC Plus Ivonescimab in Advanced Breast Cancer

Akeso Advances IO2.0 + Adc2.0 Strategy: First Patient Dosed in Phase Ii Study of Trop2/Nectin-4 Bispecific ADC (Ak146d1) Combined with Ivonescimab in Breast Cancer

THOMSON REUTERS

Mgi Tech Surges Over 19% as AI Enters Industrialization Phase, Company Provides Sequencing Tools for AI Drug Discovery

Genscript Bio's Shares Surge Over 8% Intraday as Global AI Drug Development Enters a Realization Phase

Alzheimer's Treatment Enters New Era of Disease Modification, Chinese Biotech Pipelines Show Strong Competitiveness

After 5 Months, Huabao Fund's Medical ETF (512170) Reclaims the 200-Day Moving Average! Wuxi Apptec A-Shares Break Through the Previous Bull Market Peak of the Pharmaceutical Sector, Hitting an 8-Year All-Time High

Cyclical Shifts Cannot Dim the Enduring Value of Innovative Drug Assets

Hong Kong Stock Moves | PEIJIA-B (09996) Surges Over 10% After H1 Revenue Growth of 17.4%-23.1% and TAVR Implants Up 36.5%

AI Drug Discovery Enters Validation Phase, Shares of Insilico Medicine Surge Over 11%

Leading Pharmas Ignite Market as Innovative Drugs Stage August Comeback

Keymed Biosciences (SEHK:2162) Hits A Phase III Milestone, Is The Upside Already Priced In?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1574/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":531.68604,"timestamp":1786519411885,"preClose":532.84753,"halted":0,"volume":72905201,"delay":0,"changeRate":-0.00218,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-1.161499,"latestTime":"08-12 15:23:32","open":532.796,"high":543.53937,"low":528.924,"amount":1767696367,"amplitude":0.027429,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1786522200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1786498200000,1786507200000],[1786510800000,1786521600000]],"pbRate":4.320612,"peRate":-81.172646,"turnoverRate":0.002646,"increases":10,"decrements":23,"flats":0,"marketCap":339489585456,"floatMarketCap":302563272656},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":543.53937,"amplitude":0.027429,"preClose":532.84753,"low":528.924,"pbRate":"4.320612","latestPrice":531.68604,"volume":72905201,"delay":0,"open":532.796,"prevYearClose":556.26263,"prevWeekClose":516.343,"prevMonthClose":473.313,"prevQuarterClose":453.519,"fiveDayClose":485.719,"twentyDayClose":525.18,"sixtyDayClose":579.587,"secType":"PLATE","market":"HK","turnoverRate":0.002646,"peRate":-81.172646,"marketCap":339489585456,"floatMarketCap":302563272656,"timestamp":1786519411885,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":10,"down":23,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658935955","title":"Why InnoCare Pharma (SEHK:9969) Is Up 12.9% After Dual Breakthrough Therapy Wins in Cancer and Autoimmune Disease - And What's Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2658935955","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658935955?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:35","pubTimestamp":1786358118,"startTime":"0","endTime":"0","summary":"In August 2026, InnoCare Pharma announced that its BTK inhibitor orelabrutinib, combined with BCL2 inhibitor mesutoclax, received Breakthrough Therapy Designation from China’s CDE for previously treated marginal zone lymphoma, following clinical data showing a 100% overall response rate and a favorable safety profile.\nThis recognition, alongside earlier positive Phase III results for TYK2 inhibitor fadeucravacitinib in moderate-to-severe plaque psoriasis, underscores InnoCare’s push to...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/why-innocare-pharma-sehk9969-is-up-129-after-dual-breakthrou","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/why-innocare-pharma-sehk9969-is-up-129-after-dual-breakthrou","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09969","AGIX","CHAT","ARTY","BK1161","AIPO","BK1574","QTOC","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100336884","title":"AI-Driven Drug Discovery Nears Reality: From Molecule Generation to Clinical Validation","url":"https://stock-news.laohu8.com/highlight/detail?id=1100336884","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100336884?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:31","pubTimestamp":1786357878,"startTime":"0","endTime":"0","summary":"If traditional drug development is like trying countless keys in the dark, AI's first step is not to open the door itself, but to prioritize the keys most likely to fit. In 2026, several strong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","AIPO","BK1191","ARTY","VTHR","BK1574","CHAT","AGIX","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152511864","title":"Drug Innovation and CRO Sectors Surge as Mid-Year Reports Validate Sector Uptrend","url":"https://stock-news.laohu8.com/highlight/detail?id=1152511864","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152511864?lang=en_us&edition=fundamental","pubTime":"2026-08-10 17:51","pubTimestamp":1786355469,"startTime":"0","endTime":"0","summary":"As of August 7, 22 innovative drug companies have released their first-half performance reports for 2026, with a generally positive trend. Among them, 12 reported year-on-year growth, 3 turned...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","159992","MEDX","LNGR","IBBQ","WX","CXO","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151027030","title":"AI Drug Discovery Sparks 'Tool Seller' Surge, CXO Giants Break Multiple Records! Innovative Drugs Next in Line? Fund Manager's Latest Analysis!","url":"https://stock-news.laohu8.com/highlight/detail?id=1151027030","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151027030?lang=en_us&edition=fundamental","pubTime":"2026-08-10 17:50","pubTimestamp":1786355446,"startTime":"0","endTime":"0","summary":"Since August, Hong Kong's innovative drug supply chain has reignited, with CXO stocks taking the lead. On August 10, WuXi AppTec H-shares hit a new all-time high, pushing its market cap above 600...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTOC","01477","CXO","159992","BK1161","BK1574","LNGR","IBBQ","AIPO","MEDX","VTHR","WX","ARTY","CHAT","06978","BK1191","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190555236","title":"Sichuan Huiyu Pharmaceutical Secures European Marketing Approvals for Two Injectable Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190555236","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190555236?lang=en_us&edition=fundamental","pubTime":"2026-08-10 17:40","pubTimestamp":1786354825,"startTime":"0","endTime":"0","summary":"Sichuan Huiyu Pharmaceutical Co.,Ltd. (688553.SH) has announced that its subsidiary, Seacross (Europe) Pharma Ltd., has recently received marketing authorizations from regulatory authorities in...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","BK1574","BK1191","688553","BK0239","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658989273","title":"Peijia Medical Schedules Board Meeting to Review Interim Results, Dividend Recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=2658989273","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658989273?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:40","pubTimestamp":1786351208,"startTime":"0","endTime":"0","summary":"Peijia Medical schedules board meeting to review interim results, dividend recommendationPeijia Medical will hold a board meeting on Aug. 21, 2026 to review interim results for the six months ended Ju","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL8zRYy3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","BK1583","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190579803","title":"MGI Tech's AI Unit Targets National Labs and Pharma Firms with Autonomous Lab Tools","url":"https://stock-news.laohu8.com/highlight/detail?id=1190579803","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190579803?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:25","pubTimestamp":1786350308,"startTime":"0","endTime":"0","summary":"MGI Tech Co., Ltd., a Chinese sequencing instrument manufacturer, has established an artificial intelligence subsidiary named Genoria AI to develop and commercialize laboratory tools that can...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688114","BK0251","CHAT","AIPO","ARTY","VTHR","BK1574","AGIX","01477","QTOC","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180091696","title":"SDIC Securities: Pharmaceutical Equipment Sector Enters New Quality Upgrade Phase, Focus on Top Domestic Firms","url":"https://stock-news.laohu8.com/highlight/detail?id=1180091696","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180091696?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:22","pubTimestamp":1786350145,"startTime":"0","endTime":"0","summary":" SDIC Securities has released a research report indicating that the pharmaceutical equipment industry is experiencing stable growth in scale. The bioprocess sector, driven by rapid advancements in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","BK1574","BK1191","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658835629","title":"Zai Lab Ltd : Jefferies Cuts Target Price to $36 from $52","url":"https://stock-news.laohu8.com/highlight/detail?id=2658835629","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658835629?lang=en_us&edition=fundamental","pubTime":"2026-08-10 14:57","pubTimestamp":1786345036,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN44704Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4139","LU2488822045.USD","ZLAB","BK4526","BK4531","09688","BK4548","BK4585","BK1574","BK1588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658602868","title":"Akeso Doses First Patient in Phase II Trial of Ak146d1 ADC Plus Ivonescimab in Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2658602868","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658602868?lang=en_us&edition=fundamental","pubTime":"2026-08-10 12:07","pubTimestamp":1786334823,"startTime":"0","endTime":"0","summary":"Akeso doses first patient in Phase II trial of AK146D1 ADC plus ivonescimab in advanced breast cancerAkeso dosed the first patient in a Phase II study of TROP2/Nectin-4 bispecific ADC AK146D1 combined","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDLc1w1yj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2778985437.USD","LU0348825331.USD","LU0417516571.SGD","LU0417516902.SGD","LU0417516738.SGD","LU0348766576.USD","LU1720050803.USD","LU0348735423.USD","LU0540923850.HKD","KURE","LU2476274308.USD","LU2399975544.HKD","BK1161","IE00B5MMRT66.SGD","LU2488822045.USD","LU0348827113.USD","BK1574","LU1961090484.USD","LU0634319403.HKD","09926","LU1794554557.SGD","LU2476274720.SGD","LU0561508036.HKD","LU0348784397.USD","LU0348767384.USD","IE00BPRC5H50.USD","LU0348783233.USD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658460283","title":"Akeso Advances IO2.0 + Adc2.0 Strategy: First Patient Dosed in Phase Ii Study of Trop2/Nectin-4 Bispecific ADC (Ak146d1) Combined with Ivonescimab in Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2658460283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658460283?lang=en_us&edition=fundamental","pubTime":"2026-08-10 12:06","pubTimestamp":1786334787,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA5SMJJP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0417516902.SGD","KURE","LU2476274308.USD","IE00B5MMRT66.SGD","LU0348767384.USD","LU0540923850.HKD","LU1794554557.SGD","LU0348827113.USD","LU0417516738.SGD","LU0348825331.USD","LU2778985437.USD","IE00BPRC5H50.USD","09926","BK1574","IE00B543WZ88.USD","LU0348784397.USD","LU0634319403.HKD","LU0348735423.USD","LU2399975544.HKD","LU2488822045.USD","BK1161","LU0561508036.HKD","LU1961090484.USD","LU0348766576.USD","LU0417516571.SGD","LU1720050803.USD","LU0348783233.USD","LU2476274720.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187311941","title":"Mgi Tech Surges Over 19% as AI Enters Industrialization Phase, Company Provides Sequencing Tools for AI Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=1187311941","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187311941?lang=en_us&edition=fundamental","pubTime":"2026-08-10 12:06","pubTimestamp":1786334779,"startTime":"0","endTime":"0","summary":"Mgi Tech Co.,Ltd. (688114.SH) surged over 19% in early trading, currently up 14.27% at 61.51 yuan with a turnover of 1.014 billion yuan.AI for Science is transitioning from concept to an...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","ARTY","CHAT","01477","BK0251","BK1574","688114","159982","VTHR","399300","QTOC","AIPO","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195051743","title":"Genscript Bio's Shares Surge Over 8% Intraday as Global AI Drug Development Enters a Realization Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=1195051743","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195051743?lang=en_us&edition=fundamental","pubTime":"2026-08-10 11:30","pubTimestamp":1786332624,"startTime":"0","endTime":"0","summary":"Genscript Bio (01548) shares climbed more than 8% during trading hours, and as of the time of writing, the stock was up 4.79% at HK$24.08, with a trading volume of HK$14.67 billion. The global...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","HK0000320264.USD","HK0000306701.USD","QTOC","BK1576","AIPO","BK1191","ARTY","BK1141","VTHR","CHAT","01548","HK0000306685.HKD","HK0000320223.HKD","AGIX","BK1583","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145406339","title":"Alzheimer's Treatment Enters New Era of Disease Modification, Chinese Biotech Pipelines Show Strong Competitiveness","url":"https://stock-news.laohu8.com/highlight/detail?id=1145406339","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145406339?lang=en_us&edition=fundamental","pubTime":"2026-08-10 11:28","pubTimestamp":1786332502,"startTime":"0","endTime":"0","summary":"GTHT has released a research report indicating that the Chinese neurodegenerative disease drug market is projected to be valued at approximately $2.6 billion in 2025, with expectations to grow to...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","02611","MEDX","601211","BK0183","BK0184","BK1564","BK0188","IBBQ","BK1147","LNGR","BK1161","BK0276","BK0028","BK0201","159992","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136989687","title":"After 5 Months, Huabao Fund's Medical ETF (512170) Reclaims the 200-Day Moving Average! Wuxi Apptec A-Shares Break Through the Previous Bull Market Peak of the Pharmaceutical Sector, Hitting an 8-Year All-Time High","url":"https://stock-news.laohu8.com/highlight/detail?id=1136989687","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136989687?lang=en_us&edition=fundamental","pubTime":"2026-08-10 11:20","pubTimestamp":1786332052,"startTime":"0","endTime":"0","summary":"On August 10, the A-share medical sector continued its upward momentum! The AI medical concept led the gains, with MGI Tech Co., Ltd. surging towards the 20% daily limit, and Kingmed Diagnostics...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0611395673.USD","LU2045819591.USD","159938","LU0700851271.USD","LU0348767384.USD","399300","IE00BPRC5H50.USD","LU1979443071.USD","LU1808992512.USD","BK1574","IPOS","159828","LU2125910500.SGD","BK1583","LU0320764599.SGD","LU1770034418.SGD","LU1997245094.SGD","BK1161","BK1141","LU0708995583.HKD","LU2242644610.SGD","LU0348766576.USD","LU2495084118.USD","LU0456842615.SGD","LU2488822045.USD","LU1934453819.USD","BK0216","LU1303224171.USD","IE00B543WZ88.USD","LU0052750758.USD","LU1251922891.USD","LU2328871848.SGD","LU1997245177.USD","LU1997244956.HKD","159982","LU1719994722.HKD","BK1515","IE00B5MMRT66.SGD","BK1576","LU1046422090.SGD","LU1969619763.USD","02359","603259","512170","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116594969","title":"Cyclical Shifts Cannot Dim the Enduring Value of Innovative Drug Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=1116594969","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116594969?lang=en_us&edition=fundamental","pubTime":"2026-08-10 10:32","pubTimestamp":1786329127,"startTime":"0","endTime":"0","summary":"For the innovative drug sector, the secondary market may sustain a pessimistic outlook for an extended period, and the process of restoring confidence could take longer than anticipated. However,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1161","BK1574","159992","IBBQ","MEDX","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110714993","title":"Hong Kong Stock Moves | PEIJIA-B (09996) Surges Over 10% After H1 Revenue Growth of 17.4%-23.1% and TAVR Implants Up 36.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1110714993","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110714993?lang=en_us&edition=fundamental","pubTime":"2026-08-10 10:14","pubTimestamp":1786328054,"startTime":"0","endTime":"0","summary":"PEIJIA-B (09996) surged more than 10% in Hong Kong trading, with shares last up 9.07% at HK$4.69, on turnover of HK$4.39 million.The company announced that its first-half 2026 revenue is expected to...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1583","BK1574","BK4588","09996","VXUS","159891","BK4585","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132468409","title":"AI Drug Discovery Enters Validation Phase, Shares of Insilico Medicine Surge Over 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132468409","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132468409?lang=en_us&edition=fundamental","pubTime":"2026-08-10 10:10","pubTimestamp":1786327837,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696) saw its share price jump more than 11% during intraday trading. As of the time of writing, the stock is up 7% to HK$48.62, with a trading volume of HK$567 million. Recently,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","QTOC","BK1191","VTHR","AGIX","BK1574","CHAT","01477","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199302250","title":"Leading Pharmas Ignite Market as Innovative Drugs Stage August Comeback","url":"https://stock-news.laohu8.com/highlight/detail?id=1199302250","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199302250?lang=en_us&edition=fundamental","pubTime":"2026-08-10 09:11","pubTimestamp":1786324260,"startTime":"0","endTime":"0","summary":"A first-half earnings report from the pharmaceutical sector in early August stunned the market, showing revenue of 28.9 billion yuan, up 38.9% year-on-year, and net profit attributable to...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BK1161","IBBQ","LNGR","159992","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658443604","title":"Keymed Biosciences (SEHK:2162) Hits A Phase III Milestone, Is The Upside Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2658443604","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658443604?lang=en_us&edition=fundamental","pubTime":"2026-08-10 08:28","pubTimestamp":1786321721,"startTime":"0","endTime":"0","summary":"Keymed Biosciences (SEHK:2162) is back in focus after announcing that CMG901, its CLDN18.2-targeting antibody drug conjugate co developed with AstraZeneca, met primary and key secondary overall survival endpoints in a global Phase III gastric cancer trial.\nSee our latest analysis for Keymed Biosciences.\nThe positive CMG901 news arrives after a strong run in Keymed Biosciences, with the share price at HK$81.85 and a year to date share price return of 53.13%, while the 3 year total shareholder...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2162/keymed-biosciences-shares/news/keymed-biosciences-sehk2162-hits-a-phase-iii-milestone-is-th","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2162/keymed-biosciences-shares/news/keymed-biosciences-sehk2162-hits-a-phase-iii-milestone-is-th","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","BK1587","BK1161","BK4134","III","02162","BK1583"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":3,"totalSize":208,"code":"91000000","status":"200"}]}}